Skip to main content
Premium Trial:

Request an Annual Quote

Court Upholds $7M Innogenetics Victory Over Abbott in IP-Infringement Case

NEW YORK (GenomeWeb News) — A Wisconsin court has upheld a $7-million verdict against Abbott Laboratories for infringing a patent held by Innogenetics that protects a process for typing HCV isolates, the Belgian biotech said yesterday.
The court also denied Abbott’s motion for a new trial based on “infringement and validity” and granted Innogenetics’ motion to set another hearing to consider permanently barring Abbott from selling the infringing products, Innogenetics said.
Innogenetics originally sued Abbott in September 2005, accusing the drug maker and Third Wave Technologies of infringing the patent. Third Wave settled its suit in February 2006 by taking a non-exclusive license to sell the HCV genotyping hardware and an option to extend the license to include the entire HCV patent estate.
Tried in the US District Court for the Western District of Wisconsin, the Abbott suit culminated in a jury verdict that in September 2006 awarded Innogenetics $7 million.
The judge in the case had the leeway to increase that award by as much as three times on the jury’s opinion that the infringement was willful, but declined to do so.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.